(F5) A phase I–II trial of erythropoietin [epoetin-β] (EPO) in patients with myelodysplastic syndromes (MDS)
- 31 December 1991
- journal article
- abstracts
- Published by Elsevier in Leukemia Research
- Vol. 15, 13
- https://doi.org/10.1016/0145-2126(91)90374-3
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: